Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHEMED CORPCHE · Entity 3723 | Director · president and CEO | September 28, 2026 | September 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHEMED CORP
Report date September 28, 2026 · Filed September 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital StockSEC Table I · non-derivative | Direct | 66,418 |
Reported balance
After 2026-09-28 transaction · row 1
1 source rowRow 1 · 2026-09-28 · Sale · Disposed 2,000 · Balance 66,418 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.93 to $515.12. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.93 to $515.12. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2018 Filed Feb 20, 2018 15:56 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 3,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011150 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,938 Underlying: capital stock · 3,094 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 20, 2015 vest based on achievement of performance targets over a period of January 1, 2015 to December 31, 2017. The determination of the performance level was to be made by March 15, 2018. F5 · derivative.expiration_date: PSU's awarded February 20, 2015 vest based on achievement of performance targets over a period of January 1, 2015 to December 31, 2017. The determination of the performance level was to be made by March 15, 2018. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 15:56 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 5,103 | $256.29 | $1,307,847.87 |
DisclosureSEC source: 0001209191-18-011150 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,049 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSU's. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 15:56 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 6,309 | $256.29 | $1,616,933.61 |
DisclosureSEC source: 0001209191-18-011150 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSU's that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2015 through December 31, 2017, compared to a defined peer group of companies. The Company's performance ranked in the 90th percentile of that group, yielding an award of 200%; including the reinvestment of dividends paid during such period, the award is 203.9% of target. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 15:56 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 5,043 | $256.29 | $1,292,470.47 |
DisclosureSEC source: 0001209191-18-011150 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSU's") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2015 through December 31, 2017. The actual performance of 11.79% yielded an award of 159.9% of target; including the reinvestment of dividends paid during such period, the award is 163.0% of target. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 16:00 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 5,000 | $232.59 | $1,162,950.00 |
DisclosureSEC source: 0001209191-17-061071 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,800 Read SEC document |
| November 03, 2017 Filed Nov 6, 2017 16:18 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 55,000 | $231.91 Strike: $231.91 | $12,755,050.00 |
DisclosureSEC source: 0001209191-17-059363 · doc4.xml · derivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,299 Underlying: capital stock · 55,000 shares Expires 2022-11-03 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/03/2018 Read SEC document |
| October 31, 2017 Filed Nov 1, 2017 18:13 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 10,000 | $223.42 | $2,234,200.00 |
DisclosureSEC source: 0001209191-17-058568 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,800 Read SEC document |
| October 30, 2017 Filed Nov 1, 2017 18:13 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 30,000 | $63.36 Strike: $63.36 | $1,900,800.00 |
DisclosureSEC source: 0001209191-17-058568 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,299 Underlying: capital stock · 30,000 shares Expires 2022-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: exercisable in 3 equal annual installments commencing 2/17/2013. Read SEC document |
| October 30, 2017 Filed Nov 1, 2017 18:13 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 18,216 | $226.34 | $4,123,009.44 |
DisclosureSEC source: 0001209191-17-058568 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,800 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| October 30, 2017 Filed Nov 1, 2017 18:13 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 30,000 | $63.36 | $1,900,800.00 |
DisclosureSEC source: 0001209191-17-058568 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2017 Filed Jul 31, 2017 18:40 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 30,000 | $63.36 Strike: $63.36 | $1,900,800.00 |
DisclosureSEC source: 0001209191-17-046655 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,299 Underlying: capital stock · 30,000 shares Expires 2022-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: exercisable in 3 equal annual installments commencing 2/17/2013. Read SEC document |
| July 28, 2017 Filed Jul 31, 2017 18:40 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 15,000 | $201.16 | $3,017,400.00 |
DisclosureSEC source: 0001209191-17-046655 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,016 Read SEC document |
| July 28, 2017 Filed Jul 31, 2017 18:40 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 18,785 | $201.34 | $3,782,171.90 |
DisclosureSEC source: 0001209191-17-046655 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,016 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| July 28, 2017 Filed Jul 31, 2017 18:40 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 30,000 | $63.36 | $1,900,800.00 |
DisclosureSEC source: 0001209191-17-046655 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2017 Filed May 22, 2017 19:33 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 1,142 | $198.86 | $227,098.12 |
DisclosureSEC source: 0001209191-17-034237 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,801 F1 · kind: stock award tax obligation Read SEC document |
| May 02, 2017 Filed May 2, 2017 19:59 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 4,000 | $205.11 | $820,440.00 |
DisclosureSEC source: 0001209191-17-029162 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,943 Read SEC document |
| April 28, 2017 Filed May 2, 2017 19:59 UTC | CHEMED CORP CHE · Entity 3723 | Giftcapital stock | 248 | $203.18 | $50,388.64 |
DisclosureSEC source: 0001209191-17-029162 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,943 Read SEC document |
| March 03, 2017 Filed Mar 3, 2017 18:33 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 7,000 | $181.74 | $1,272,180.00 |
DisclosureSEC source: 0001209191-17-017119 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,191 Read SEC document |
| February 24, 2017 Filed Feb 24, 2017 18:45 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 3,819 | $176.85 | $675,390.15 |
DisclosureSEC source: 0001209191-17-014211 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,191 Read SEC document |
| February 23, 2017 Filed Feb 24, 2017 18:45 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 3,181 | $178.56 | $567,999.36 |
DisclosureSEC source: 0001209191-17-014211 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,010 Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 14:25 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 4,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012474 · doc4.xml · derivative · entry 7 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,032 Underlying: capital stock · 4,314 shares Expires not disclosed F7 · derivative.exercise_price: each performance stock unit represents a contingent right to receive one share of Chemed capital stock F8 · derivative.exercise_date: PSU's vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2017 - December 31, 2019. The determination of the performance level is to be made by March 15, 2020 and earned shares to be delivered thereafter F8 · derivative.expiration_date: PSU's vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2017 - December 31, 2019. The determination of the performance level is to be made by March 15, 2020 and earned shares to be delivered thereafter Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 14:25 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 3,051 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012474 · doc4.xml · derivative · entry 6 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,718 Underlying: capital stock · 3,051 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F6 · derivative.exercise_date: PSU's awarded November 7, 2014 vest based on achievement of performance targets over a period of January 1, 2014 to December 31, 2016. The determination of the performance level was to be made by March 15, 2017. F6 · derivative.expiration_date: PSU's awarded November 7, 2014 vest based on achievement of performance targets over a period of January 1, 2014 to December 31, 2016. The determination of the performance level was to be made by March 15, 2017. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 14:25 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 4,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012474 · doc4.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,769 Underlying: capital stock · 4,149 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F6 · derivative.exercise_date: PSU's awarded November 7, 2014 vest based on achievement of performance targets over a period of January 1, 2014 to December 31, 2016. The determination of the performance level was to be made by March 15, 2017. F6 · derivative.expiration_date: PSU's awarded November 7, 2014 vest based on achievement of performance targets over a period of January 1, 2014 to December 31, 2016. The determination of the performance level was to be made by March 15, 2017. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 14:25 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 3,589 | $172.60 | $619,461.40 |
DisclosureSEC source: 0001209191-17-012474 · doc4.xml · nonDerivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,191 F4 · kind: stock award tax obligation Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 14:25 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 5,298 | $172.60 | $914,434.80 |
DisclosureSEC source: 0001209191-17-012474 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,780 F3 · kind: Shares withheld to satisfy tax obligations in connection with vesting of PSU's. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 14:25 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 6,242 | $172.60 | $1,077,369.20 |
DisclosureSEC source: 0001209191-17-012474 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The number of PSU's that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2014 through December 31, 2016, compared to a defined peer group of companies. The Company's performance ranked in the 91st percentile of that group, yielding an award of 200%; including the reinvestment of dividends paid during such period, the award is 204.6% of target. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 14:25 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 4,896 | $172.60 | $845,049.60 |
DisclosureSEC source: 0001209191-17-012474 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The number of performance share units ("PSU's") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2014 through December 31, 2016. The actual performance of 8.23% yielded an award of 115.4% of target; including the reinvestment of dividends paid during such period, the award is 118.0% of target. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 15:58 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 90,800 | $135.85 Strike: $135.85 | $12,335,180.00 |
DisclosureSEC source: 0001209191-16-148522 · doc4.xml · derivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,299 Underlying: capital stock · 90,800 shares Expires 2021-11-04 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/04/2017 Read SEC document |
| October 31, 2016 Filed Oct 31, 2016 19:54 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 2,358 | $138.38 | $326,301.45 |
DisclosureSEC source: 0001209191-16-147422 · doc4.xml · nonDerivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,940 Read SEC document |
| October 28, 2016 Filed Oct 31, 2016 19:54 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 26,000 | $63.36 Strike: $63.36 | $1,647,360.00 |
DisclosureSEC source: 0001209191-16-147422 · doc4.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,499 Underlying: capital stock · 26,000 shares Expires 2022-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: exercisable in 3 equal annual installments commencing 2/17/2013. Read SEC document |
| October 28, 2016 Filed Oct 31, 2016 19:54 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 7,642 | $138.41 | $1,057,698.65 |
DisclosureSEC source: 0001209191-16-147422 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,298 Read SEC document |
| October 28, 2016 Filed Oct 31, 2016 19:54 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 18,326 | $138.07 | $2,530,270.82 |
DisclosureSEC source: 0001209191-16-147422 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,940 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| October 28, 2016 Filed Oct 31, 2016 19:54 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 26,000 | $63.36 | $1,647,360.00 |
DisclosureSEC source: 0001209191-16-147422 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.